Today's News |
Global Health Sciences Fund Invests US $2 Million in Ai-Driven Digital Medical Device From PhysIQ
Wednesday, August 2, 2017Company Profile | Follow Company
Vancouver, BC, Aug 2, 2017--(T-Net)--The Global Health Sciences (GHS) Fund through Quark Venture and GF Securities have announced a US$2 million investment in PhysIQ, a Chicago-based leader in developing solutions that leverage artificial intelligence (AI) to empower digital health for ambulatory patient monitoring and clinical trial support.
This supports the organizations' mandate to invest globally in breakthrough health technology.
VitaLink solution promises to transform both post-acute care and clinical trials implementation.
Quark Venture's Chief Scientific Officer, Zafrira Avnur, will also join the PhysIQ Board of Directors. Read the full-press release here.
About Quark Ventures
Established in 2015, Quark Venture is focused on equity financing of innovative biotechnology and health sciences companies with breakthrough technology platforms and projects.
Our strategic goal is to support and enable companies we invest in to grow, create value and be successful by providing not only financial support, but also developmental, infrastructure and expertise support, as needed, through our global network.
Our approach is to establish long-term relationships with target companies, with a view to enable and strengthen management to realize the full potential and value of the technology. This approach has previously been successfully demonstrated in the energy and high-tech sectors where Quark Venture partners have invested.
While Quark Venture is headquartered in Vancouver, it has offices in Boston, Hong Kong and Chengdu, and plans to establish a European office in 2017.
Company Snapshot |
||
Vancouver, BC, Canada. (Non-Tech Sectors)
|